Skip to main content
Premium Trial:

Request an Annual Quote

Thomas Neyarapally

Premium
Gene Network Sciences has hired Thomas Neyarapally as vice president of corporate strategy and intellectual property. Neyarapally was previously an associate in the New York office of the intellectual property firm Frommer, Lawrence & Haug, where he specialized in life sciences and worked with pharmaceutical and biotech companies. Neyarapally was previously a corporate associate at Chadbourne & Parke and an analyst at Arthur D. Little.

Filed under

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.